Running a Study
4 Minute Read
CRIO sites were nearly 30% of U.S. COV19 Vaccine Sites. What this means for eSource adoption
The daunting task of COVID-19 trials The onset of the COVID-19 pandemic posed a new challenge for sponsors. They needed to execute clinical trials at a rate that has never been accomplished before. To succeed, they needed sites that could conduct the trials at unprecedented speed. These are sites with short start-up times, existing large...